Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
Psoriasis; This is a spontaneous report received from an Other HCP. A male patient received BNT162b2 (COMIRNATY), in 2020 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PSORIASIS (non-serious), outcome "unknown". Additional information: A Pfizer vaccine sales representative was talking to a physician assistant that shared that he personally experienced a side effect with the Covid vaccine and he wanted to report that incident. He experienced Psoriasis, a very severe case of Psoriasis. The patient got the vaccine many years ago, like 2020. He just shared it with the Pfizer vaccine sales representative. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.